Synthesis,characterization and catalytic properties of cationic N-heterocyclic carbene silver complexes

Three new dibenzimidazolium salts bridged by 2-methylenepropane-1,3-diyl group were synthesized. Their dinuclear N-heterocyclic carbene Ag(I) complexes were prepared by the reactions of these salts with Ag₂O. The structures of the synthesized compounds were defined by nuclear magnetic resonance (NMR), Fourier-transform infrared spectroscopy (FT-IR), elemental analysis, and LC-MSMS (for complexes) techniques. Stability of the silver complexes was confirmed by ¹H NMR spectroscopy. Catalytic activities of Ag(I) compounds were tested for three-component coupling reaction of some aldehydes, amines, and phenylacetylene.     

Experimental and theoretical studies of a silver complex of O-functionalized N-heterocyclic carbene

Experimental and theoretical studies of a silver complex namely, [1-i-propyl-3-(2-oxo-2-t-butyl ethyl)imidazol-2-ylidene]AgCl (1b), supported over an O-functionalized N-heterocyclic carbene ligand are reported. Specifically, [1-i-propyl-3-(2-oxo-2-t-butyl ethyl)imidazol-2-ylidene]AgCl (1b) was synthesized by reaction of 1-i-propyl-3-(2-oxo-2-t-butyl ethyl)imidazolium chloride 1a with Ag₂O in 42% yield. The 1-i-propyl-3-(2-oxo-2-t-butyl ethyl)imidazolium chloride 1a was synthesized by the alkylation reaction of 1-i-propylimidazole with α-chloropinacolone in 70% yield. The molecular structures of 1a and 1b have been determined by X-ray diffraction. Detailed theoretical investigation has been performed using the density functional theory method with the B3LYP functional. Bonding in 1b has been probed with the help of charge decomposition analysis (CDA), atoms in molecule (AIM) approach as well as natural bond orbital (NBO) methods. The Ag-NHC bond has a dominantly covalent character with NHC acting as an effective σ-donor. The π-back-bonding from the metal to the ligand was found to be negligible.     

Synthesis and characterization of indenyl-functionalized N-heterocyclic carbene complex of Ni(II)

A new type of Ind-NHC ligand precursor (Ind = indenyl), [C₉H₇-(CH₂)₃-(CH{NCHCHNⁱPr})]Br (HL·HBr, 1), was designed and prepared. The reaction of in situ generated anionic indenyl-functionalized NHC ligand LLi with (DME)NiCl₂ affords a novel mono-ligand Ni(II) bromide, [C₉H₆-(CH₂)₃-(C{NCHCHNⁱPr})]NiBr (2), which was characterized by elemental analysis, NMR and X-ray crystal determination. Complex 2 in combination with NaBPh₄ can catalyze the polymerization of styrene at 80 °C.     

Synthesis and structure of N-heterocyclic carbene complexes of rhodium and iridium derived from an imidazolium-linked cyclophane

This paper describes the synthesis, spectroscopic and structural characterisation, and electrochemical behaviour of some rhodium and iridium complexes of the form LM(X₁)(X₂)⁺, where L is a chelating bis(carbene) derived from an imidazolium-linked ortho-cyclophane. The complexes where X₁/X₂ = 1,5-cycooctadiene or norbornadiene were prepared from the imidazolium-linked cyclophane and the appropriate metal source. In these complexes, the M-L bonding was quite robust, but the diene could be displaced by CO to give the dicarbonyl complexes , from which one or both carbonyl ligands could be displaced by monodentate or bidentate phosphines, respectively. Structural studies revealed only minor variations in the cyclophane unit upon exchange of the ancillary ligands, in each case the rhodium complex being isomorphous with its iridium analogue. In cyclovoltammetric studies of LRh(dppe)⁺, reversible Rh(I/II) and Rh(II/III) redox couples were observed. The other rhodium complexes displayed more complex electrochemical behaviours and did not undergo simple reversible redox reactions.     

Structure and reactivity of a new anionic N-heterocyclic carbene silver(I) complex

The efficient synthesis of aN-benzoyliminoimidazolium ylide provides access to a new type of N-hetereocyclic anionic carbene, from which air stable Ag(I) and Cu(II) complexes and a catalytically active Rh(I) complex were formed.     

Synthesis and structural characterisation of the first N-heterocyclic carbene ligand fused to a porphyrin

The functionalisation of two neighboring beta-pyrrolic positions of a porphyrin by a fused N-heterocyclic carbene ligand, the subsequent metallation of this external coordination site by palladium(II) and the structural characterisation of the resulting compounds are presented.     

Synthesis and structural characterisation of rhodium hydride complexes bearing N-heterocyclic carbene ligands

Addition of excesses of N-heterocyclic carbenes (NHCs) IEt₂Me₂, IⁱPr₂Me₂ or ICy (IEt₂Me₂ = 1,3-diethyl-4,5-dimethylimidazol-2-ylidene; IⁱPr₂Me₂ = 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene; ICy = 1,3-dicyclohexylimidazol-2-ylidene) to [HRh(PPh₃)₄] (1) affords an isomeric mixture of [HRh(NHC)(PPh₃)₂] (NHC = IEt₂Me₂ (cis-/trans-2), IⁱPr₂Me₂ (cis-/trans-3), ICy (cis-/trans-4) and [HRh(NHC)₂(PPh₃)] (IEt₂Me₂(cis-/trans-5), IⁱPr₂Me₂ (cis-/trans-6), ICy (cis-/trans-7)). Thermolysis of 1 with the aryl substituted NHC, 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene (IMesH₂), affords the bridging hydrido phosphido dimer, [{(PPh₃)₂Rh}₂(μ-H)(μ-PPh₂)] (8), which is also the reaction product formed in the absence of carbene. When the rhodium precursor was changed from 1 to [HRh(CO)(PPh₃)₃] (9) and treated with either IMes (=1,3-dimesitylimidazol-2-ylidene) or ICy, the bis-NHC complexes trans-[HRh(CO)(IMes)₂] (10) and trans-[HRh(CO)(ICy)₂] (11) were formed. In contrast, the reaction of 9 with IⁱPr₂Me₂ gave [HRh(CO)(IⁱPr₂Me₂)₂] (cis-/trans-12) and the unusual unsymmetrical dimer, [(PPh₃)₂Rh(μ-CO)₂Rh(IⁱPr₂Me₂)₂] (13). The complexes trans-3, 8, 10 and 13 have been structurally characterised.     

Synthesis and characterization of half-sandwich N-heterocyclic carbene complexes of cobalt and rhodium

A series of novel half-sandwich M(I) and M(III) complexes (M = Co, Rh) bearing the N-heterocyclic carbene ligand 1,3-dimesitylimidazol-2-ylidene (IMes) have been prepared and characterized. Thus, (eta5-C(5)R(5))M(IMes)(C(2)H(4))(M = Co, Rh; R = H, Me) were obtained from the corresponding bis(ethene) complexes (eta5-C(5)R(5))M(C(2)H(4))(2), except for CpRh(IMes)(C(2)H(4)) which was prepared via the novel 16-electron Rh(I) compound Rh(IMes)(C(2)H(4))(2)Cl. The carbonyl compounds (eta5-C(5)R(5))Co(IMes)(CO)(R = H, Me) were synthesized by thermal CO substitution of (eta5-C(5)R(5))Co(CO)(2). A diamagnetic, apparently 16-electron Co(III) compound [CpCo(IMes)I](+)[I(3)(-)] was obtained from CpCo(IMes)(CO) and I(2). Finally, Co(III) and Rh(III) complexes CpCo(IMes)Me(2) and Cp*Rh(IMes)Me(2) were prepared by methylation of [CpCo(IMes)I](+)[I(3)(-)], and ligand exchange at Cp*Rh(Me(2)SO)Me(2), respectively. The molecular structures of CpCo(IMes)(CO), CpRh(IMes)(C(2)H(4)), Cp*Rh(IMes)(C(2)H(4)), and Cp*Rh(IMes)Me(2) were determined by single crystal X-ray diffraction. Steric and electronic factors imposed by the strongly donating and sterically demanding IMes ligand are discussed on the basis of X-ray crystallographic, NMR, and IR spectroscopic analyses. Very poor correlations are found between values for (1)J(Rh-C(carbene)) and dRh-C(carbene) data for Rh(i) N,N-heterocyclic carbene complexes including literature data and this work.     

Synthesis and crystallographic characterization of multi-donor N-heterocyclic carbene chelating ligands and their silver complexes: Potential use in pharmaceuticals

The potential for N-heterocyclic carbenes (NHCs) to be used as novel chelating ligands for bio-inorganic pharmaceuticals is discussed. In this paper, we design, synthesize and characterize two NHC precursors, 6 and 7, that we believe have potential for use as metal chelators for pharmaceuticals. The NHC precursors are composed of imidazolium and pyridine rings that would form mixed donor NHCs upon metallation with medicinally relevant metals. The exploration of the silver chemistry of 6 yielded the dimeric silver NHC complex 8[BPh₄]₂. The study of the silver chemistry of 7 gave 9[1/3(Ag₄Br₇)] and 10[NO₃]₃. Complex 9[1/3(Ag₄Br₇)] appears to be a silver biscarbene charge balanced by a silver bromide anionic cluster. Complex 10[NO₃]₃ is a trinuclear silver cluster that is stabilized by NHCs and pyridine rings. Silver NHCs have shown themselves to be excellent transmetallation agents for access to other metal NHC systems. It is envisioned that the silver NHCs 8[BPh₄]₂, 9[1/3(Ag₄Br₇)] and 10[NO₃]₃ will readily transfer to medicinally relevant metals, such ¹⁰⁵Rh.     

Synthesis and characterization of N-heterocyclic carbene complexes of uranium(III)

Reaction of [(((Ad)ArO)(3)tacn)U(III)] (1) or [((Me(3)Si)(2)N)(3)U(III)] (3) with tetramethylimidazol-2-ylidene (Me(4)IMC:) yields novel N-heterocyclic carbene complexes [(((Ad)ArO)(3)tacn)U(III)(Me(4)IMC:)] (2) and [((Me(3)Si)(2)N)(3)U(III)(Me(4)IMC:)] (4). Uranium complexes 2 and 4 represent the first examples of compounds with an N-heterocyclic carbene ligand coordinated to a low-valent uranium center. The paramagnetic complexes 1, 2, and 4 were characterized by (1)H NMR, UV-vis-NIR, and EPR spectroscopy as well as SQUID magnetization measurements and X-ray diffraction analyses. DFT studies indicate a significant degree of pi-bonding in the U(III)-carbene entity.     

Synthesis and reactions of N-heterocyclic carbene boranes

Boranes are widely used Lewis acids and N-heterocyclic carbenes (NHCs) are popular Lewis bases, so it is remarkable how little was known about their derived complexes until recently. NHC-boranes are typically readily accessible and many are so stable that they can be treated like organic compounds rather than complexes. They do not exhibit "borane chemistry", but instead are proving to have a rich chemistry of their own as reactants, as reagents, as initiators, and as catalysts. They have significant potential for use in organic synthesis and in polymer chemistry. They can be used to easily make unusual complexes with a broad spectrum of functional groups not usually seen in organoboron chemistry. Many of their reactions occur through new classes of reactive intermediates including borenium cations, boryl radicals, and even boryl anions. This Review provides comprehensive coverage of the synthesis, characterization, and reactions of NHC-boranes.     

Synthesis and reactivity of alkyl-palladium N-heterocyclic carbene complexes

The transamination of alkyl-palladium halide N-heterocyclic carbene complexes has enabled the isolation of products that reveal interesting insights into the factors which might be barriers to the development of a palladium-catalysed alkyl-amination reaction.     

Synthesis and structural characterization of tin analogues of N-heterocyclic carbenes

The synthesis and X-ray crystal structures of five N-heterocyclic stannylenes are reported. These compounds, containing a variety of backbones, were prepared by the salt metathesis of the appropriate dilithiated diamide with SnCl(2) and show a high degree of thermal stability compared to the corresponding species with unsaturated backbones. If bulky diisopropylphenyl groups are attached to the nitrogen centers then the structures are monomeric, but when the less bulky mesityl groups are employed the solid-state structure was shown to be dimeric.     

A bimetallic N-heterocyclic carbene complex featuring a short Cr-Cr distance

The alkylation of a chelating bis(carbene) complex of CrCl(2) yields an unusual bimetallic complex featuring a short Cr-Cr distance, novel ligand coordination, and CH(3) ligand exchange.     

Enhanced cytotoxicity of silver complexes bearing bidentate N-heterocyclic carbene ligands

A diverse library of cationic silver complexes bearing bis(N-heterocyclic carbene) ligands have been prepared which exhibit cytotoxicity comparable to cisplatin against the adenocarcinomas MCF7 and DLD1. Bidentate ligands show enhanced cytotoxicity over monodentate and macrocyclic ligands.     

Synthesis and reactivity of triethylborane adduct of N-heterocyclic carbene: versatile synthons for synthesis of N-heterocyclic carbene complexes

The reaction of an imidazolium salt with LiBEt(3)H afforded triethylborane adduct of imidazol-2-ylidene, which can act as a carbene precursor for the synthesis of a transition metal complex as well as a main group element complex.     

Synthesis and characterization of N-heterocyclic carbene palladium complex and its application on direct arylation of benzoxazoles and benzothiazoles with aryl bromides

A mixed-halogen bis(1-(4-tert-butylbenzyl)-3-(2, 4, 6-trimethylbenzyl)-1H-benzo[d]imidazol-2-ylidene) palladium(II) complex, trans-[Pd(Cl_0.7Br_0.3)₂(C₂₈H₃₂N₂)₂], has been synthesized and characterized by elemental analysis, ¹H-NMR, ¹³C-NMR, and IR spectroscopy, and single crystal X-ray diffraction. The palladium in the mononuclear complex is four-coordinate in a square-planar configuration with two carbenes of two benzo[d]imidazole rings and two halides. The two halides are disordered between Br and Cl, with the Cl: Br ratio approximately 0.7 : 0.3. The angles C1–Pd1–Br1, 88.63(11)° and C1ⁱ–Pd1–Br1ⁱ, 91.37(11)° (i: 1?x, 1?y, 1?z) in the coordination sphere are very close to the ideal value of 90°. The Pd–X distance is slightly longer than other carbene derivative Pd–Cl single bond distances and slightly shorter than Pd–Br single bond distances. These results agree with the Cl/Br disorder at the halogen position. The palladium–carbene complex was tested as a catalyst in the direct arylation reaction of benzoxazoles and benzothiazoles with aryl bromides.     

Synthesis and anticancer properties of gold(I) and silver(I) N-heterocyclic carbene complexes

Bis(1,3-dimethylimidazol-2-ylidene)silver(I) nitrate and bis(4,5-dichloro-1,3-dimethylimidazol-2-ylidene)silver(I) nitrate were prepared by reacting the corresponding imidazolium nitrate salts with silver oxide. Bis(1,3-dimethylimidazol-2-ylidene)gold(I) nitrate and bis(4,5-dichloro-1,3-dimethylimidazol-2-ylidene)gold(I) nitrate salts were prepared via transmetallation of their silver precursors with chloro dimethylsulfide gold. The anticancer properties were determined using NCI-H460 lung cancer cells. Efficacy was established by comparison of the gold and silver compounds with cisplatin.